Unknown statusInterventionalNot ApplicableLast updated Oct 4, 2021

Atrial Sensing Capability for Better Detection of Atrial Fibrillation

A Prospective, Multicenter, Randomized Controlled Trial Comparing Atrial Sensing ON-mode of VDD Implantable Cardioverter Defibrillator(ICD) to Atrial Sensing OFF-mode of VDD ICD in Detecting Atrial Fibrillation(Smart-Control Study)

Overview

ClinicalTrials.gov ID: NCT03932604
Lead Sponsor: Samsung Medical CenterOTHER
Brief Summary: This prospective multi-center randomized controlled study aims to compare atrial fibrillation detection and inappropriate therapy according to activation of atrial sensing capability in patients with implantable cardioverter defibrillator.
Study Type: Interventional

Status

Overall Status: Unknown status
Start Date: Jun 1, 2019Actual
Primary Completion Date: Dec 31, 2021Estimated
Completion Date: May 31, 2023Estimated

Study Record Dates

First Submitted: Apr 28, 2019
First Submitted that Met QC Criteria: Apr 28, 2019
First Posted: May 1, 2019Actual
Last Update Submitted that Met QC Criteria: Sep 27, 2021
Last Update Posted: Oct 4, 2021Actual
Last Verified: Jun 2021

NCT03110627Unknown status

Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead

NCT02186704Completed

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

NCT00324662Completed

Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)

NCT00661037Completed

SAFEty of Two Strategies of ICD Management at Implantation

NCT03477734Completed

Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation

NCT00870324Completed

OptiSense™ Performance in Detecting Atrial Episodes